Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Seikagaku. the Journal of Japanese Biochemical Society
|
April 27, 2001
[AGE and AGE-receptors]
N Ohgami, R Nagai, H Nakayama, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 12, 2000
[Glibenclamide inhibits cholesterol metabolism in macrophage]
H Nakayama, N Ohgami, A Kuniyasu, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products
N Ohgami, R Nagai, A Miyazaki, et al.
Journal of Agricultural and Food Chemistry
|
November 23, 2000
Crystal structure and conformation of beta-substituted (Z)- and (E)-6-styrylpurines as conformer models
S Nishikawa, H Mizuno, N Ohgami, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2000
Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme
N Ohgami, A Kuniyasu, K Furukawa, et al.
The Journal of Biological Chemistry
|
October 18, 2000
Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products
N Ohgami, R Nagai, M Ikemoto, et al.
Annals of the New York Academy of Sciences
|
January 25, 2002
CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products
N Ohgami, R Nagai, M Ikemoto, et al.
The Kurume Medical Journal
|
January 1, 1994
A study of reservoir implantation--especially with saphenous vein graft catheterization
K Kosuga, N Ohgami, H Kinoshita, et al.
The Kurume Medical Journal
|
January 1, 1993
Transfusion-associated graft versus host disease following hepatectomy for hepatocellular carcinoma--a case report
K Kosuga, N Ohgami, K Okuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[The study of continuous arterial infusion chemotherapy with 5-FU and CDDP in patients with hepatocellular carcinoma]
I Yanagi, A Koga, K Aso, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Seikagaku. the Journal of Japanese Biochemical Society
|
April 27, 2001
[AGE and AGE-receptors]
N Ohgami, R Nagai, H Nakayama, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
January 12, 2000
[Glibenclamide inhibits cholesterol metabolism in macrophage]
H Nakayama, N Ohgami, A Kuniyasu, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products
N Ohgami, R Nagai, A Miyazaki, et al.
Journal of Agricultural and Food Chemistry
|
November 23, 2000
Crystal structure and conformation of beta-substituted (Z)- and (E)-6-styrylpurines as conformer models
S Nishikawa, H Mizuno, N Ohgami, et al.
Biochemical and Biophysical Research Communications
|
October 18, 2000
Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme
N Ohgami, A Kuniyasu, K Furukawa, et al.
The Journal of Biological Chemistry
|
October 18, 2000
Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products
N Ohgami, R Nagai, M Ikemoto, et al.
Annals of the New York Academy of Sciences
|
January 25, 2002
CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products
N Ohgami, R Nagai, M Ikemoto, et al.
The Kurume Medical Journal
|
January 1, 1994
A study of reservoir implantation--especially with saphenous vein graft catheterization
K Kosuga, N Ohgami, H Kinoshita, et al.
The Kurume Medical Journal
|
January 1, 1993
Transfusion-associated graft versus host disease following hepatectomy for hepatocellular carcinoma--a case report
K Kosuga, N Ohgami, K Okuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[The study of continuous arterial infusion chemotherapy with 5-FU and CDDP in patients with hepatocellular carcinoma]
I Yanagi, A Koga, K Aso, et al.
Page
of 2